Clonidine Patch, Extended Release
NDC Package 75907-024-48
Package Information
Clonidine patches is a medication used alone or with other medications to treat high blood pressure (hypertension). This formulation utilizes a patch, extended release delivery system. Marketed by Dr. Reddy's Labratories Inc., this product is identified by NDC 75907-024 and is authorized under FDA application ANDA079090.
Identification & Billing
- RxCUI: 998671 - cloNIDine HCl 0.1 MG/Day Weekly Transdermal System
- RxCUI: 998671 - 168 HR clonidine 0.00417 MG/HR Transdermal System
- RxCUI: 998671 - clonidine HCl 0.1 MG/Day Weekly Transdermal System
- RxCUI: 998671 - clonidine hydrochloride 0.1 MG/Day Weekly Transdermal Patch
- RxCUI: 998675 - cloNIDine HCl 0.2 MG/Day Weekly Transdermal System
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 75907 - Dr. Reddy's Labratories Inc.
- 75907-024 - Clonidine
- 75907-024-48 - 4 POUCH in 1 CARTON / 1 PATCH in 1 POUCH (75907-024-11) / 24 h in 1 PATCH
- 75907-024 - Clonidine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 75907-024-48 identifies a specific commercial package of 4 pouch in 1 carton / 1 patch in 1 pouch (75907-024-11) / 24 h in 1 patch of Clonidine, a human prescription drug labeled by Dr. Reddy's Labratories Inc.. This patch, extended release is formulated for transdermal use and contains clonidine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dr. Reddy's Labratories Inc. on February 10, 2024. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used alone or with other medications to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Clonidine belongs to a class of drugs (central alpha agonists) that act in the brain to lower blood pressure. It works by relaxing blood vessels so blood can flow more easily.
How is this Dr. Reddy's Labratories Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 75907002448. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.